Fatal lung and kidney damage associated with calcium-ceftriaxone precipitates has been observed in premature and term neonates. Preg class A . Total duration of therapy (which may include oral step-down therapy) is 4 to 7 days following adequate source control (SIS [Mazuski 2017]; SIS/IDSA [Solomkin 2010]); for infections managed without surgical or percutaneous intervention, a longer duration may be necessary (Barshak 2019; Pemberton 2019).IV: 2 g every 12 hours; for empiric therapy, use in combination with other appropriate agents. Although not all of these side effects may occur, if they do occur they may need medical attention.Check with your doctor or nurse immediately if any of the following side effects occur while taking ceftriaxone:

Controlled studies in pregnant women show no evidence of fetal risk.Inhibits cell-wall synthesis by binding to penicillin-binding proteins; resistant to most beta-lactamasesPenetrates well into most body fluids and tissues; CSF concentrations approximate those in plasmaMetabolized in liver to open beta-lactam form (inactive)Half-life: Normal renal function, 1-1.5 hr; CrCl >30-80 mL/min, 1.9-3.3 hr; CrCl >2-30 mL/min, 3.82-5.7 hrAdditive: Amphotericin B, metronidazole, multivitaminsAdminister IV infusion over 15-30 minutes; administer IV bolus over 3-5 minutesAdding plans allows you to compare formulary status to other drugs in the same class.To view formulary information first create a list of plans. Increased serum levels w/ CYP3A4 inhibitors (e.g. The Brand Name NIFERIL-R Has Generic Salt :: Nifedipine  NIFERIL-R  Is From Company U S V Priced :: Rs. Management: Avoid cholera vaccine in patients receiving systemic antibiotics, and within 14 days following the use of oral or parenteral antibiotics.Lactobacillus and Estriol: Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol. Could Antibiotics Make Breast Milk Less Healthy for Babies?




Diseases & Conditions

Compare formulary status to other drugs in the same class. Low concentrations of ceftriaxone are excreted in breast milk that are "not expected to …

May also be given as empiric therapy for gram-negative bloodstream infection in hemodynamically stable, immunocompetent patients without health care exposures (Moehring 2019).IV: 1 g once daily for 5 to 7 days; may switch to oral therapy following clinical improvement (Friedland 2004; GOLD 2020; Sethi 2020; Wilson 2003).IV: 1 to 2 g once daily in combination with other appropriate agents. It works by stopping the growth of bacteria. It has not been observed to cause birth defects in animal studies, but a lack of well-controlled studies done in pregnant women exists.

Ceftriaxone is recommended for use in pregnant women for the treatment of gonococcal infections, Lyme disease, and may be used in certain situations prior to vaginal delivery in women at high risk for endocarditis (consult current guidelines) (ACOG 199 2018; CDC [Workowski 2015]; Wormser 2006).• It is used to treat or prevent bacterial infections.• Pancreatitis like severe abdominal pain, severe back pain, severe nausea, or vomiting.• Gallstones like pain in the upper right abdominal area, right shoulder area, or between the shoulder blades; yellow skin; or fever with chills.• Kidney problems like unable to pass urine, blood in the urine, change in amount of urine passed, or weight gain.• Hemolytic anemia like severe loss of strength and energy, dark urine, or yellow skin.• Kidney stone like back pain, abdominal pain, or blood in the urine.• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.
Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.

#K channel blockers.

Contact the applicable plan provider for the most current information. Total duration (which may include oral step-down therapy) is for a minimum of 5 days; patients should be clinically stable with normal vital signs prior to discontinuation (ATS/IDSA [Metlay 2019]).IV: 2 g every 24 hours for 4 to 6 weeks; for empiric therapy, use as part of an appropriate combination regimen (IDSA [Osmon 2013]; Berbari 2019).IV: 1 to 2 g every 24 hours for 3 to 14 days (7 to 14 days in HIV-infected patients with a CD4 count ≥200 cells/mmIV: 2 g once daily. 2002